HealthLytix to Launch CT CoPilot at RSNA 2018

SAN DIEGO, Nov. 9, 2018 /PRNewswire/ -- HealthLytix, a precision health company and developer of quantitative medical imaging solutions that leverage machine learning announces the release of CT CoPilot™ at the upcoming Radiological Society of North America (RSNA) 2018 annual meeting in Chicago. CT CoPilot seamlessly integrates into existing workflow to improve radiologist efficiency, measurement accuracy, and clinical confidence by automatically generating consistent views of head CT exams. It also provides automated quantitative measurements and subtraction series to increase conspicuity of change between exams.

Dr. Nikdokht Farid, Associate Professor of Radiology, Neuroradiology Division, UCSD, states that CT CoPilot "quickly and automatically provides correctly aligned images, which enables me to read head CT scans faster and more confidently. It has increased my productivity and has become indispensable in my interpretation of head CTs."

Studies performed at UC San Diego have shown that CT CoPilot can improve reader certainty by 23% when determining increased ventricular volume and by 14% when determining decreased ventricular volume. Related research showed that CT CoPilot reduced the average radiologist interpretation time by 73% when assessing for change in ventricular volume, without sacrificing clinical accuracy.

"We recognized that the dramatic increase in radiologist workload is driving the need for greater productivity while maintaining clinical confidence and diagnostic accuracy. ", says Nathan White, CTO at HealthLytix.  "We expect CT CoPilot to be well received by neuroradiologists and those who rely upon CT scans to manage trauma patients".

CT CoPilot is currently in clinical testing and will be commercially available in early 2019. HealthLytix personnel will be available to discuss the benefits and capabilities of CT CoPilot in the CorTechs Labs Booth #7944 – North Hall at RSNA.

About HealthLytix:
At HealthLytix, we create data analytics solutions to provide comprehensive insights into health status based on genetics, quantitative imaging, and other medical information. Our products provide consumers with the benefits of early detection and targeted care, while empowering physicians with more accurate clinical decision-making across medical imaging modalities. As a precision health company, we apply proprietary machine learning algorithms to create individualized wellness assessments. We enable physicians and health systems to understand patient data, personalize treatment solutions and leverage data-driven insights into care pathway management. Learn more at www.healthlytix.com and in our virtual press kit.

SOURCE HealthLytix